Logo
x

Search

Subscribe Now

Postpartum Depression

Sage Therapeutics' Zulresso (brexanolone) Receives FDA's Approval for Postpartum Depression (PPD)

Sage Therapeutics' Zulresso (brexanolone) Receives FDA's Approval for Postpartum Depression (PPD)

  • March 20, 2019
Sage Reports Voting Results from FDA Advisory Committees for Zulresso (brexanolone) to Treat Postpartum Depression (PPD)

Sage Reports Voting Results from FDA Advisory Committees for Zulresso (brexanolone) to Treat Postpartum Depression (PPD)

  • November 5, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.